Dear Researchers,

The library will be closed between August 10, 2026 and August 16, 2026. During this period, it will be possible to upload publications, but all other services will be suspended.

Thank you for your understanding.

Kardos Tamás

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2010-2024

2024

Gálffy, G., Szabó, G. T., Tamási, L., Müller, V., Moldvay, J., Sárosi, V., Kerpel-Fronius, A., Kardos, T., Csada, E., Pápai-Székely, Z., Szász, Z., Király, Z., Hódi, G., Kovács, Z., Balogh, É., Kovács, K. A., Darida, M., Buga, V., Rokszin, G., Abonyi-Tóth, Z., Kiss, Z., Vokó, Z., Bogos, K.: Decreasing incidence and mortality of lung cancer in Hungary between 2011 and 2021 revealed by robust estimates reconciling multiple data sources.
Pathol. Oncol. Res. 30, 1-11, (article identifier: 1611754), 2024.

doi DEA WoS Scopus

Journal metrics:

Q3 Cancer Research

Q2 Medicine (miscellaneous)

Q2 Oncology

Q2 Pathology and Forensic Medicine

Lieber, A., Makai, A., Orosz, Z., Kardos, T., Susil, J. I., Tornyi, I., Bittner, N.: The role of immunotherapy in early stage and metastatic NSCLC.
Pathol. Oncol. Res. 30, 1-17, (article identifier: 1611713), 2024.

doi DEA Scopus

Journal metrics:

Q3 Cancer Research

Q2 Medicine (miscellaneous)

Q2 Oncology

Q2 Pathology and Forensic Medicine

2023

Lázár, J., Antal-Szalmás, P., Kurucz, I., Ferenczi, A., Józsi, M., Tornyi, I., Müller, M., Fekete, J. T., Lamont, J., FitzGerald, P., Gall-Debreceni, A., Kádas, J., Vida, A., Tardieu, N., Kieffer, Y., Jullien, A., Guergova-Kuras, M., Hempel, W., Kovács, A. L., Kardos, T., Bittner, N., Csánky, E., Szilasi, M., Losonczy, G., Szondy, K., Gálffy, G., Csada, E., Szalontai, K., Somfay, A., Malka, D., Cottu, P., Bogos, K., Takács, L.: Large-scale plasma proteome epitome profiling is an efficient tool for the discovery of cancer biomarkers.
Mol. Cell. Proteomics. 22 (7), 1-18, (article identifier: 100580), 2023.

doi DEA Scopus

Journal metrics:

D1 Analytical Chemistry

D1 Biochemistry

D1 Medicine (miscellaneous)

Q1 Molecular Biology

2022

Makai, A., Kovács, T., Lieber, A., Kardos, T., Orosz, Z., Vaskó, A., Bittner, N., Takács, I.: Nintedanib kezelés 4 év távlatában.
Med. Thorac. 75 (3), 159, 2022.

DEA

Tóth, L. J., Takács, I., Váradi, C., Kóder, G., Kardos, T., Endes, G., Orlik, B., Baráth, L., Méhes, G.: Óriássejtes csonttumor tüdőáttétei: esetismertetés.
Med. Thorac. 75 (3), 218, 2022.

DEA

2020

Tóth, Z., Forgács, L., Kardos, T., Kovács, R. L., Locke, J. B., Kardos, G., Nagy, F., Borman, A. M., Adnan, A., Majoros, L.: Relative Frequency of Paradoxical Growth and Trailing Effect with Caspofungin, Micafungin, Anidulafungin, and the Novel Echinocandin Rezafungin against Candida Species.
J. Fungi. 6 (3), 1-9, (article identifier: 136), 2020.

doi DEA WoS Scopus

Journal metrics:

D1 Ecology, Evolution, Behavior and Systematics

Q1 Microbiology (medical)

D1 Plant Science

2019

Lázár, J., Nur, S., Antal-Szalmás, P., Losonczy, G., Szilasi, M., Kardos, T., Szondy, K., Gálffy, G., Csánky, E., Somfay, A., Takács, L.: Plasma protein epitomics profiling detects lung cancer association of various clinical parameters (gender, BMI, copd, staging).

DEA

2018

Tóth, Z., Kardos, T., Kovács, R. L., Kardos, G., Nagy, F., Prépost, E., Barta, Z., Takács, I., Majoros, L.: Comparison of Killing Activity of Micafungin Against Six Candida Species Isolated from Peritoneal and Pleural Cavities in RPMI-1640, 10 and 30% Serum.
Mycopathologia. 183 (6), 905-912, 2018.

doi DEA

Journal metrics:

Q2 Agronomy and Crop Science

Q2 Applied Microbiology and Biotechnology

Q3 Microbiology

Q2 Plant Science

Q1 Veterinary (miscellaneous)

Kardos, T., Kovács, R. L., Kardos, G., Varga, I., Bozó, A., Tóth, Z., Nagy, F., Majoros, L.: Poor in vivo efficacy of caspofungin, micafungin and amphotericin B against wild-type Candida krusei clinical isolates does not correlate with in vitro susceptibility results.
J. Chemother. 30 (4), 233-239, 2018.

doi DEA

Journal metrics:

Q3 Infectious Diseases

Q2 Medicine (miscellaneous)

Q3 Oncology

Q3 Pharmacology

Q3 Pharmacology (medical)

2017

10.

Kardos, T., Horváth, Z.: A gefitinib-kezelés agyi metastasisokat adó tüdőtumorban és emlőtumorban szenvedő betegnél: esetbemutatás.
Med. Thorac. 69 (5), 309-311, 2017.

DEA

11.

Saleh, Q., Kovács, R. L., Kardos, G., Gesztelyi, R., Kardos, T., Bozó, A., Majoros, L.: Decreased Killing Activity of Micafungin Against Candida guilliermondii, Candida lusitaniae, and Candida kefyr in the Presence of Human Serum.
Microb. Drug Resist. 23 (6), 764-770, 2017.

doi DEA

Journal metrics:

Q3 Immunology

Q1 Medicine (miscellaneous)

Q2 Microbiology

Q2 Microbiology (medical)

Q2 Pharmacology

12.

Kovács, R. L., Saleh, Q., Bozó, A., Tóth, Z., Gesztelyi, R., Kardos, T., Kardos, G., Takács, I., Majoros, L.: Killing Activity of Micafungin Against Candida albicans, C. dubliniensis and Candida africana in the Presence of Human Serum.
Mycopathologia. 182 (11-12), 979-987, 2017.

doi DEA

Journal metrics:

Q2 Agronomy and Crop Science

Q2 Applied Microbiology and Biotechnology

Q3 Microbiology

Q2 Plant Science

Q2 Veterinary (miscellaneous)

13.

Kardos, T., Saleh, Q., Kovács, R. L., Gesztelyi, R., Kardos, G., Bozó, A., Tóth, Z., Majoros, L.: Postantifungal effect of micafungin against Candida albicans, Candida dubliniensis and Candida africana in the presence and absence of serum.
New Microbiol. 40 (4), 286-288, 2017.

DEA

Journal metrics:

Q2 Medicine (miscellaneous)

Q2 Microbiology (medical)

2016

14.

Domán, M., Kovács, R. L., Kardos, G., Gesztelyi, R., Juhász, B., Bozó, A., Kardos, T., Saleh, Q., Majoros, L.: Killing rates of caspofungin in 50 percent serum correlate with caspofungin efficacy against Candida albicans in a neutropenic murine model.
Current Drug Del. 13 (2), 255-264, 2016.

doi DEA

Journal metrics:

Q2 Pharmaceutical Science

15.

Jánváry, Z. L., Simon, M., Dér, Á., Szántó, E., Fodor, A., Kardos, T., Szilasi, M., Horváth, Z.: Sztereotaxiás sugárterápia: új, kuratív terápiás lehetőség az inoperábilis I. stádiumú nem-kissejtes tüdőrák kezelésében.
Medicina Thoracalis. 69 (3), 13-137, 2016.

DEA

2015

16.

Kardos, T., Szilasi, M.: Immunterápia: ígéretes lehetőség a daganatok kezelésében?.
Med. Thorac. 68 (6), 380-383, 2015.

DEA

2011

17.

Tamási, L., Müller, V., Eszes, N., Kardos, T., Budai, M., Vincze, K., Losonczy, G., Szilasi, M.: Patterns of erythropoiesis-stimulating agent use for chemotherapy-induced anemia in lung cancer: results of a retrospective Hungarian real-life clinical data analysis.
Expert Opin. Drug Saf. 10 (4), 503-507, 2011.

doi DEA

Journal metrics:

Q1 Medicine (miscellaneous)

Q2 Pharmacology (medical)

2010

18.

Szabó, P., Brugós, L., Koncz, A., Kardos, T., Nagy, J., Szilasi, M.: The safety of transthoracic core cutting needle biopsy.
In: 16th World Congress for Bronchology World Congress for Bronchoesophagology Program and Abstractsgy / Magyar Tüdőgyógyász Társaság Magyar Bronchológus Egyesülete, Magyar Tüdőgyógyász Társaság, Budapest, 89-90, 2010.

DEA